Shanghai Rightongene Biotechnology Co (SHSE:688217) Tax Provision: ¥-19.2 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688217 Shanghai Rightongene Biotechnology Co Ltd SHSE:688217
62 GF Score
Price ¥24.65
GF Value ¥16.05
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Shanghai Rightongene Biotechnology Co Tax Provision?

Shanghai Rightongene Biotechnology Co SHSE:688217 +0.49% 62 Tax Provision is ¥-19.2 Mil as of Jun. 2026. GuruFocus rates SHSE:688217 with a GF Score™ of 62/100 and a GF Value™ of ¥16.05 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Shanghai Rightongene Biotechnology Co's tax provision for the three months ended in Jun. 2026 was ¥-8.4 Mil. Its tax provision for the trailing twelve months (TTM) ended in Jun. 2026 was ¥-19.2 Mil.

Shanghai Rightongene Biotechnology Co Tax Provision Historical Data

* Premium members only.

The historical data trend for Shanghai Rightongene Biotechnology Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rightongene Biotechnology Co Tax Provision Chart

Shanghai Rightongene Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Provision
Get a 7-Day Free Trial Premium Member Only -2.37 -5.56 4.60 2.57 -9.69

Shanghai Rightongene Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.17 1.97 -13.90 1.14 -8.44
SHSE:688217
62GF Score
Shanghai Rightongene Biotechnology Co Ltd SHSE:688217
Tax Provision is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Rightongene Biotechnology Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-19.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of ¥-19.2 Mil mean?
Shanghai Rightongene Biotechnology Co (SHSE:688217) has a Tax Provision of ¥-19.2 Mil as of Jun. 2026. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Shanghai Rightongene Biotechnology Co and its competitors.
Is Shanghai Rightongene Biotechnology Co's Tax Provision too high?
Shanghai Rightongene Biotechnology Co's current Tax Provision is ¥-19.2 Mil. Overall, Shanghai Rightongene Biotechnology Co has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rightongene Biotechnology Co's Tax Provision compare to VRTX and REGN?
Shanghai Rightongene Biotechnology Co's Tax Provision of ¥-19.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Biotechnology company?
A good Tax Provision depends on the Biotechnology industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Shanghai Rightongene Biotechnology Co and its competitors. Shanghai Rightongene Biotechnology Co's current Tax Provision is ¥-19.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rightongene Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rightongene Biotechnology Co (SHSE:688217) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥16.05, compared to a current price of ¥24.65 — trading 53.6% above its estimated fair value. The current Tax Provision is ¥-19.2 Mil. Shanghai Rightongene Biotechnology Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Shanghai Rightongene Biotechnology Co (SHSE:688217), the current Tax Provision is ¥-19.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Rightongene Biotechnology Co (SHSE:688217) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Rightongene Biotechnology Co stock appears to be overvalued. The current stock price of ¥24.65 is trading 53.6% above its estimated GF Value™ of ¥16.05. GuruFocus considers Shanghai Rightongene Biotechnology Co to be Significantly Overvalued.

Key valuation signals for SHSE:688217:

  • Tax Provision: ¥-19.2 Mil
  • GF Value™: ¥16.05 vs. price of ¥24.65 (53.6% above fair value)
  • GF Score™: 62/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Rightongene Biotechnology Co Business Description

Address No. 6055, Jinhai Road, Building 3, Fengxian District, Shanghai, CHN, 201499
Shanghai Rightongene Biotechnology Co Ltd is engaged in the research and development, production, sales, scientific research and testing services of in vitro diagnostic products.
62GF Score

Get the complete analysis for SHSE:688217

Tax Provision is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.65
Price
¥16.05
GF Value